MEADE HARRY 4
4 · GTC BIOTHERAPEUTICS INC · Filed Nov 4, 2009
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Award
Common Stock
2009-11-02$1.21/sh+13,598$16,454→ 29,452 total
Holdings
- 5,302(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]These shares were awarded as part of the Reporting Person's bonus compensation for fiscal year 2008 based on the closing price of $1.21 of the Issuer's Common Stock on November 2, 2009.